NCT00346008View on ClinicalTrials.gov

Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members

CompletedOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

February 28, 2009

Conditions
Melanoma (Skin)
Interventions
GENETIC

mutation analysis

OTHER

high performance liquid chromatography

OTHER

laboratory biomarker analysis

OTHER

questionnaire administration

Trial Locations (1)

105

Iceland Genomics Corporation, Reykjavik

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Iceland Genomics Corporation

INDUSTRY

NCT00346008 - Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members | Biotech Hunter | Biotech Hunter